Update date
30 Jun 2019
Shareable Research Card
RCEL - AVITA Medical, Inc. Interest Expense
This metric view shows RCEL - AVITA Medical, Inc. interest expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2019
- Latest reported value
- A$37,769
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2019
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2019.
- Latest reported value on this page: A$37,769.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Interest Expense
Latest reported interest expense: A$37,769. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2019
SEC-backed company facts were refreshed from filings filed on 06 Aug 2026.
Benchmark Context
How Interest Expense compares with peers
AVITA Medical, Inc. sits in the lower half of the current interest expense sample.
Compared with
Compared with 11 companies reporting interest expense in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 1x the current sample midpoint. Interest Expense is up about 42% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2019 to 30 Jun 2025.
- Nearby companies in this sample: Locafy Ltd and Nova Minerals Corp.
- Current sample position: rank #6 of 11 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
AVITA Medical, Inc.: Interest Expense
Latest period: 2019. Period end: 30 Jun 2019. Units: AUD. Frequency: annual.
Interest Expense is reported in company XBRL facts filed with the SEC.
Metric snapshot
- Latest value
- A$37,769
- Coverage range
- 30 Jun 2017 - 30 Jun 2019
- Fact rows
- 3
What this metric tells you
- Shows reported interest expense over 30 Jun 2017 - 30 Jun 2019.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 3 SEC fact rows for this metric and issuer.
How to read this chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC source
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Interest Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
AVITA Medical, Inc. appears at rank #6 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | WESTPAC BANKING CORP | A$35,594,000,000 | Year - 30 Sep 2024 | Open WESTPAC BANKING CORP Interest Expense |
| 2 | Gelteq Ltd (gels) | A$1,917,720 | Year - 30 Jun 2025 | Open Gelteq Ltd Interest Expense |
| 3 | Australian Oilseeds Holdings Ltd (coot) | A$991,614 | Year - 30 Jun 2025 | Open Australian Oilseeds Holdings Ltd Interest Expense |
| 4 | Telix Pharmaceuticals Ltd (tlx) | A$82,000 | Year - 31 Dec 2024 | Open Telix Pharmaceuticals Ltd Interest Expense |
| 5 | Locafy Ltd (lcfy) | A$78,461 | Year - 30 Jun 2024 | Open Locafy Ltd Interest Expense |
| 6 | AVITA Medical, Inc. (rcel) | A$37,769 | Year - 30 Jun 2019 | Open AVITA Medical, Inc. Interest Expense |
Metric Details
- Metric
- Interest Expense (InterestExpense)
- Frequency coverage
-
annual
Comparability: Compare annual with annual and quarterly with quarterly
- Taxonomy
- ifrs-full
- Units tracked
- AUD
- History range
-
30 Jun 2017 - 30 Jun 2019
Freshness: From parsed SEC XBRL facts on this page
- Facts on this page
-
3
Source: SEC company facts API
- SEC metric endpoint
- Open SEC company concept
Metric identity
Names, identifiers, and filing context for this profile.
1 identity field
Metric coverage
3 source fields
Source evidence
Original filing metadata and source links for verification.
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Interest Expense, Annual (AUD)
Interest Expense, YoY Annual Change (%)
AVITA Medical, Inc. Annual Interest Expense (AUD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2019 | A$37,769 | +A$11,183 | +42% | 01 Jul 2018 | 30 Jun 2019 | 20-F/A | 19 Nov 2019 | 2019 | FY |
| 2018 | A$26,586 | +A$13,832 | +108% | 01 Jul 2017 | 30 Jun 2018 | 20-F/A | 19 Nov 2019 | 2019 | FY |
| 2017 | A$12,754 | 01 Jul 2016 | 30 Jun 2017 | 20-F/A | 19 Nov 2019 | 2019 | FY |
* marks a reported value that did not pass the local value check.